Cargando…

Protein-Restricted Diets for Ameliorating Motor Fluctuations in Parkinson's Disease

Levodopa is considered to be the most effective symptomatic drug for Parkinson's disease (PD). As the disease progresses, however, the patients are likely to experience a reduced response to levodopa and develop motor fluctuations (i.e., end-of-dose wearing off and unpredictable “on-off”). Prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Luxi, Xiong, Nian, Huang, Jinsha, Guo, Shiyi, Liu, Ling, Han, Chao, Zhang, Guoxin, Jiang, Haiyang, Ma, Kai, Xia, Yun, Xu, Xiaoyun, Li, Jie, Liu, Jing Y., Wang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487390/ https://www.ncbi.nlm.nih.gov/pubmed/28701947 http://dx.doi.org/10.3389/fnagi.2017.00206

Ejemplares similares

Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects
por: Ma, Kai, et al.
Publicado: (2018)

Histone Deacetylase 4 Inhibition Reduces Rotenone-Induced Alpha-Synuclein Accumulation via Autophagy in SH-SY5Y Cells
por: Wang, Luxi, et al.
Publicado: (2023)

A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects
por: Shen, Yan, et al.
Publicado: (2016)

Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management
por: Guo, Shiyi, et al.
Publicado: (2017)

Impulsive and Compulsive Behaviors in Parkinson’s Disease
por: Zhang, Guoxin, et al.
Publicado: (2014)

Melatonin ameliorates Parkinson’s disease via regulating microglia polarization in a RORα‐dependent pathway
por: Li, Jingwen, et al.
Publicado: (2022)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
por: Zhang, Guoxin, et al.
Publicado: (2018)

Genetic Variants in GAPDH Confer Susceptibility to Sporadic Parkinson’s Disease in a Chinese Han Population
por: Liu, Ling, et al.
Publicado: (2015)

Exosomes and Their Therapeutic Potentials of Stem Cells
por: Han, Chao, et al.
Publicado: (2016)

Effectiveness of Traditional Chinese Medicine as an Adjunct Therapy for Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Zhang, Guoxin, et al.
Publicado: (2015)

HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell Model
por: Huang, Jinsha, et al.
Publicado: (2017)

Novel VPS13A Gene Mutations Identified in Patients Diagnosed with Chorea-acanthocytosis (ChAc): Case Presentation and Literature Review
por: Shen, Yan, et al.
Publicado: (2017)

Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement
por: Hou, Lingling, et al.
Publicado: (2015)

Excessive Daytime Sleepiness in Parkinson’s Disease
por: Liu, Hanshu, et al.
Publicado: (2022)

Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations
por: Fernandes, Mariana, et al.
Publicado: (2021)

Investigation on sleep and mental health of patients with Parkinson's disease during the Coronavirus disease 2019 pandemic
por: Xia, Yun, et al.
Publicado: (2020)

Editorial comments: treatment of motor fluctuations in Parkinson’s disease
por: Korczyn, Amos D.
Publicado: (2011)

Nausea as a non-motor fluctuation in Parkinson’s disease
por: Weisbach, Emily, et al.
Publicado: (2022)

Gender differences in non-motor fluctuations in Parkinson’s disease
por: Donzuso, Giulia, et al.
Publicado: (2023)

Microglia as modulators of exosomal alpha-synuclein transmission
por: Xia, Yun, et al.
Publicado: (2019)

Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2021)

Impact of non-motor fluctuations on QOL in patients with Parkinson’s disease
por: Kakimoto, Asako, et al.
Publicado: (2023)

Associations Between Fluctuations in Daytime Sleepiness and Motor and Non‐Motor Symptoms in Parkinson's Disease
por: Höglund, Arja, et al.
Publicado: (2020)

Development of a Non-Motor Fluctuation Assessment Instrument for Parkinson Disease
por: Kleiner-Fisman, Galit, et al.
Publicado: (2011)

Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
por: Borgohain, Rupam, et al.
Publicado: (2014)

Randomized, Controlled Study of Opicapone in Japanese Parkinson's Patients with Motor Fluctuations
por: Takeda, Atsushi, et al.
Publicado: (2020)

Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks
por: Ramesh, Vishwajith, et al.
Publicado: (2022)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
por: Virmani, Tuhin, et al.
Publicado: (2016)

Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations
por: Modi, Nishit B., et al.
Publicado: (2019)

Long-term safety and efficacy of opicapone in Japanese Parkinson’s patients with motor fluctuations
por: Takeda, Atsushi, et al.
Publicado: (2021)

Rapid motor fluctuations reveal short-timescale neurophysiological biomarkers of Parkinson’s disease
por: Ahn, Minkyu, et al.
Publicado: (2020)

Validation of the PD home diary for assessment of motor fluctuations in advanced Parkinson’s disease
por: Löhle, Matthias, et al.
Publicado: (2022)

mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s disease
por: Erb, M. Kelley, et al.
Publicado: (2020)

Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson’s Disease: An Exploratory Study
por: Carpi, Matteo, et al.
Publicado: (2023)

Adjunct rasagiline to treat Parkinson’s disease with motor fluctuations: a randomized, double-blind study in China
por: Zhang, Zhenxin, et al.
Publicado: (2018)

Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2009)

Tryptophan in the diet ameliorates motor deficits in a rotenone‐induced rat Parkinson's disease model via activating the aromatic hydrocarbon receptor pathway
por: Wang, Yilin, et al.
Publicado: (2021)

Glucocerebrosidase L444P mutation confers genetic risk for Parkinson’s disease in central China
por: Wang, Youpei, et al.
Publicado: (2012)

Assessing Motor Fluctuations in Parkinson’s Disease Patients Based on a Single Inertial Sensor
por: Pérez-López, Carlos, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0eoksgsdi46ro04htp3omv1l7q